Skip to main content

COMMUNITY CASE STUDY article

Front. Psychiatry
Sec. Anxiety and Stress Disorders
Volume 15 - 2024 | doi: 10.3389/fpsyt.2024.1387186
This article is part of the Research Topic Traumatic Brain Injury and Post-Traumatic Stress Disorder: From Neurobiology to Treatment View all 5 articles

Massed Treatment of Posttraumatic Stress Disorder, Traumatic Brain Injury, and Co-Occurring Conditions: The Home Base Intensive Outpatient Program for Military Veterans and Service Members

Provisionally accepted
Laura K. Harward Laura K. Harward *René M. Lento René M. Lento Andrew Teer Andrew Teer Stephanie Samph Stephanie Samph Megan Parmenter Megan Parmenter Joseph Bonvie Joseph Bonvie Charlotte Magee Charlotte Magee Lauren Brenner Lauren Brenner Kaitlin Picard Kaitlin Picard Wesley Sanders Wesley Sanders William J. Tinney William J. Tinney Cyrielle Andrew Cyrielle Andrew Jessica Covitz Jessica Covitz Katrina Echevarria Katrina Echevarria Ryan Vanderweit Ryan Vanderweit Nicolette Maggiolo Nicolette Maggiolo Kaloyan S. Tanev Kaloyan S. Tanev
  • Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States

The final, formatted version of the article will be published soon.

    The two-week Home Base Intensive Clinical Program (ICP) provides treatment to veterans and active duty service members suffering from primary diagnoses of posttraumatic stress disorder (PTSD), traumatic brain injury (TBI), anxiety, or depression. First launched in 2015 (Harvey et al., 2019), this paper provides a programmatic update, including new treatment components implemented since inception, and examines outcomes for all participants who entered the program from September 2015 to July 2024 (n = 2561). The Home Base ICP provides a massed care approach through daily individual Prolonged Exposure, Cognitive Processing Therapy, Unified Protocol, or cognitive rehabilitation, along with groups targeting coping skills. Participants entering the program are provided with core group programming, as well as individualized therapy sessions tailored to their unique needs and symptom presentation. Supplemental dual recovery support is also available for all participants with co-occurring substance use or behavioral addiction concerns. Participants’ support people receive education, support, and case management services. Participants have a multidisciplinary team comprising therapists, psychopharmacology providers, case managers, nurses, and wellness providers. Results demonstrate that program participants exhibited statically significant reductions in PTSD symptoms (Cohen’s d = 0.80), depression (d = 0.68), post-concussion symptoms (d = 0.71), and increased satisfaction in social roles (d = -0.65). Completion rate was 94.60% (n = 2422), suggesting that the Home Base ICP is a well-received and effective model of care for veterans and service members.

    Keywords: military, PTSD - Posttraumatic stress disorder, Massed treatment, military mental health, Veteran mental health, Intensive Outpatient Program

    Received: 16 Feb 2024; Accepted: 08 Oct 2024.

    Copyright: © 2024 Harward, Lento, Teer, Samph, Parmenter, Bonvie, Magee, Brenner, Picard, Sanders, Tinney, Andrew, Covitz, Echevarria, Vanderweit, Maggiolo and Tanev. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Laura K. Harward, Massachusetts General Hospital, Harvard Medical School, Boston, 02114, Massachusetts, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.